| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.036 | 0.8 |